skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,069,656  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity
Material Type:
Article
Add to My Research

Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity

Cancer discovery, 2017-05, Vol.7 (5), p.522-538

ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.CD-16-0932

Full text available

2
Novel Anti-LY6G6D/CD3 T-Cell–Dependent Bispecific Antibody for the Treatment of Colorectal Cancer
Material Type:
Article
Add to My Research

Novel Anti-LY6G6D/CD3 T-Cell–Dependent Bispecific Antibody for the Treatment of Colorectal Cancer

Molecular cancer therapeutics, 2022-04, Vol.21 (6) [Peer Reviewed Journal]

ISSN: 1535-7163 ;EISSN: 1538-8514

Full text available

3
CT Colonography for Radiographers: A Guide to Performance and Image Interpretation
Material Type:
Book
Add to My Research

CT Colonography for Radiographers: A Guide to Performance and Image Interpretation

ISBN: 9783319293776 ;ISBN: 331929377X ;EISBN: 9783319293790 ;EISBN: 3319293796 ;OCLC: 957699992

Full text available

4
Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration Perspective
Material Type:
Article
Add to My Research

Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration Perspective

JNCI : Journal of the National Cancer Institute, 2021-04, Vol.114 (1) [Peer Reviewed Journal]

ISSN: 0027-8874 ;EISSN: 1460-2105

Full text available

5
Retraction: Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis
Material Type:
Article
Add to My Research

Retraction: Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis

Frontiers in oncology, 2024, Vol.14, p.1383366-1383366 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383366 ;PMID: 38440228

Full text available

6
Retraction: Effects of Aidi injection on life quality and incidence of adverse reactions in patients with non-small cell lung cancer compared with traditional chemotherapy: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Retraction: Effects of Aidi injection on life quality and incidence of adverse reactions in patients with non-small cell lung cancer compared with traditional chemotherapy: a systematic review and meta-analysis

Frontiers in oncology, 2024, Vol.14, p.1383346-1383346 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383346 ;PMID: 38440226

Full text available

7
Retraction: Establishment of criteria for molecular differential diagnosis of MPC and IPM
Material Type:
Article
Add to My Research

Retraction: Establishment of criteria for molecular differential diagnosis of MPC and IPM

Frontiers in oncology, 2024, Vol.14, p.1399853-1399853 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1399853 ;PMID: 38577339

Full text available

8
Retraction: Evaluation of the safety of retroperitoneal laparoscopic partial nephrectomy by investigating the perioperative indicators
Material Type:
Article
Add to My Research

Retraction: Evaluation of the safety of retroperitoneal laparoscopic partial nephrectomy by investigating the perioperative indicators

Frontiers in oncology, 2024, Vol.14, p.1383340-1383340 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383340 ;PMID: 38440232

Full text available

9
Retraction: Meta analysis of clinical prognosis of radiofrequency ablation versus partial nephrectomy in the treatment of early renal cell carcinoma
Material Type:
Article
Add to My Research

Retraction: Meta analysis of clinical prognosis of radiofrequency ablation versus partial nephrectomy in the treatment of early renal cell carcinoma

Frontiers in oncology, 2024, Vol.14, p.1383353-1383353 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383353 ;PMID: 38444681

Full text available

10
Retraction: Overexpressed tumor suppressor exosomal miR-15a-5p in cancer cells inhibits PD1 expression in CD8+T cells and suppresses the hepatocellular carcinoma progression
Material Type:
Article
Add to My Research

Retraction: Overexpressed tumor suppressor exosomal miR-15a-5p in cancer cells inhibits PD1 expression in CD8+T cells and suppresses the hepatocellular carcinoma progression

Frontiers in oncology, 2024, Vol.14, p.1388383-1388383 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1388383 ;PMID: 38505586

Full text available

11
Retraction: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: a retrospective analysis
Material Type:
Article
Add to My Research

Retraction: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: a retrospective analysis

Frontiers in oncology, 2024, Vol.14, p.1383410-1383410 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383410 ;PMID: 38444679

Full text available

12
Retraction: The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer
Material Type:
Article
Add to My Research

Retraction: The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer

Frontiers in oncology, 2024, Vol.14, p.1383383-1383383 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383383 ;PMID: 38450197

Full text available

13
Retraction: A study on expression level and nutritional status of IGFBP-2 after left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles in the treatment of esophageal cancer
Material Type:
Article
Add to My Research

Retraction: A study on expression level and nutritional status of IGFBP-2 after left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles in the treatment of esophageal cancer

Frontiers in oncology, 2024, Vol.14, p.1383394-1383394 [Peer Reviewed Journal]

Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383394 ;PMID: 38450196

Full text available

14
Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin
Material Type:
Article
Add to My Research

Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin

Frontiers in oncology, 2023-12, Vol.13, p.1337635-1337635 [Peer Reviewed Journal]

Copyright © 2023 Frontiers Editorial Office. ;Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1337635 ;PMID: 38130993

Full text available

15
Retraction: New insights into molecular signalling pathways and current advancements in prostate cancer diagnostics and therapeutics
Material Type:
Article
Add to My Research

Retraction: New insights into molecular signalling pathways and current advancements in prostate cancer diagnostics and therapeutics

Frontiers in oncology, 2023-12, Vol.13, p.1343833-1343833 [Peer Reviewed Journal]

Copyright © 2023 Frontiers Editorial Office. ;Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1343833 ;PMID: 38130994

Full text available

16
Retraction: Long noncoding RNA LOC400043 (LINC02381) inhibits gastric cancer progression through regulating Wnt signaling pathway
Material Type:
Article
Add to My Research

Retraction: Long noncoding RNA LOC400043 (LINC02381) inhibits gastric cancer progression through regulating Wnt signaling pathway

Frontiers in oncology, 2023-12, Vol.13, p.1298859-1298859 [Peer Reviewed Journal]

Copyright © 2023 Frontiers Editorial Office. ;Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1298859 ;PMID: 38115901

Full text available

17
Retraction: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors
Material Type:
Article
Add to My Research

Retraction: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors

Frontiers in oncology, 2023-10, Vol.13, p.1301668-1301668 [Peer Reviewed Journal]

Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1301668

Full text available

18
Retraction: Exosomes from cancer-associated mesenchymal stem cells transmit TMBIM6 to promote the malignant behavior of hepatocellular carcinoma via activating PI3K/AKT pathway
Material Type:
Article
Add to My Research

Retraction: Exosomes from cancer-associated mesenchymal stem cells transmit TMBIM6 to promote the malignant behavior of hepatocellular carcinoma via activating PI3K/AKT pathway

Frontiers in oncology, 2023-10, Vol.13, p.1307333-1307333 [Peer Reviewed Journal]

Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1307333

Full text available

19
Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway
Material Type:
Article
Add to My Research

Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway

Frontiers in oncology, 2023-10, Vol.13, p.1298871-1298871 [Peer Reviewed Journal]

Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1298871

Full text available

20
Retraction: AnnexinA5 might suppress the phenotype of human gastric cancer cells via ERK pathway
Material Type:
Article
Add to My Research

Retraction: AnnexinA5 might suppress the phenotype of human gastric cancer cells via ERK pathway

Frontiers in oncology, 2023-09, Vol.13, p.1294881-1294881 [Peer Reviewed Journal]

Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1294881

Full text available

Results 1 - 20 of 1,069,656  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (921,940)

Refine My Results

Creation Date 

From To
  1. Before 1960  (4,054)
  2. 1960 To 1975  (14,879)
  3. 1976 To 1991  (58,201)
  4. 1992 To 2008  (224,489)
  5. After 2008  (769,616)
  6. More options open sub menu

Subject 

  1. Oncology  (993,128)
  2. Science & Technology  (957,976)
  3. Life Sciences & Biomedicine  (945,899)
  4. Humans  (595,784)
  5. Female  (328,509)
  6. Male  (252,716)
  7. Tumors  (209,037)
  8. Middle Aged  (206,785)
  9. Biological And Medical Sciences  (185,544)
  10. Medical Sciences  (171,735)
  11. Cancer  (169,880)
  12. Aged  (168,089)
  13. Adult  (167,052)
  14. Animals  (160,596)
  15. Medicine  (143,273)
  16. Cancer Research  (134,543)
  17. Medicine & Public Health  (130,957)
  18. Prognosis  (106,998)
  19. Chemotherapy  (106,249)
  20. Patients  (103,816)
  21. More options open sub menu

Language 

  1. English  (1,052,948)
  2. Japanese  (141,150)
  3. Portuguese  (8,907)
  4. German  (6,724)
  5. French  (2,735)
  6. Spanish  (2,728)
  7. Polish  (925)
  8. Turkish  (805)
  9. Norwegian  (789)
  10. Chinese  (585)
  11. Russian  (450)
  12. Korean  (297)
  13. Swedish  (135)
  14. Catalan  (108)
  15. Czech  (45)
  16. Italian  (40)
  17. Afrikaans  (33)
  18. Croatian  (32)
  19. Slovenian  (31)
  20. BokmÃ¥l, Norwegian  (26)
  21. More options open sub menu

Searching Remote Databases, Please Wait